Factors influencing dosing and concentrations of sirolimus in de novo heart transplant recipients.

被引：0
|
作者：
Akhlaghi, F
Zahir, H
Keogh, AM
机构：
[1] Univ Rhode Isl, Kingston, RI 02881 USA
[2] St Vincents Hosp, Heart Lung Transplant Unit, Sydney, NSW 2010, Australia
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
049
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] Sirolimus in de novo heart transplant recipients with severe renal impairment
    de Prada, JAV
    Vilchez, FG
    Cobo, M
    Ruisanchez, C
    Valls, MF
    Ruano, J
    Piñera, C
    Duran, RM
    TRANSPLANT INTERNATIONAL, 2006, 19 (03) : 245 - 248
  • [2] Features of ''de novo'' HCV infection in heart transplant (HTx) recipients.
    Fagiuoli, S
    DeMaria, N
    Colantoni, A
    Faruki, H
    VanThiel, DH
    Cooper, DKC
    Zuhdi, N
    GASTROENTEROLOGY, 1996, 110 (04) : A1188 - A1188
  • [3] Sirolimus in Heart Transplant Recipients - Review of Sirolimus Dosing Strategies and Conversions
    Ho, K.
    Wai, M.
    Do, V.
    Sen, S.
    Maenza, C.
    Renauer, M.
    Landrum, B.
    Heeney, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S495 - S496
  • [4] De novo anorectal cancers in renal transplant recipients.
    Rudich, SM
    Buell, JF
    Beebe, TM
    Gross, TG
    Hanaway, MJ
    Alloway, RR
    Trofe, J
    Woodle, ES
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 433 - 433
  • [5] Outcomes from De Novo Tacrolimus Weight-Based Dosing Compared to Conservative Dosing in Kidney Transplant Recipients.
    Summers, B.
    Szempruch, K.
    Harris, M.
    Quidley, A.
    Haisch, C.
    Maldonado, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 786 - 787
  • [6] Evaluation of a dosing algorithm to adjust sirolimus trough levels in renal transplant recipients.
    Holt, DW
    Brattström, C
    Burke, JT
    Zimmerman, J
    TRANSPLANTATION, 2000, 69 (08) : S155 - S155
  • [7] LCP-Tacrolimus (LCPT; Envarsus XR) Dosing Considerations in De Novo Kidney Transplant Recipients.
    Cibrik, D.
    West-Thielke, P.
    Patel, S. J.
    Stevens, D. R.
    Meier-Kriesche, U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 543 - 543
  • [8] Sirolimus Monotherapy in Liver Transplant Recipients with De Novo Tumors
    Alegre Torrado, C.
    Jimenez Romero, C.
    Manrique Municio, A.
    Alvaro Cifuentes, E.
    Cambra Molero, F.
    Calvo Pulido, J.
    Abradelo de Usera, M.
    Garcia-Sesma, A.
    Sanabria Mateos, R.
    Olivares Pizarro, S.
    Garcia Aroz, S.
    Justo Alonso, I.
    Fakih, N.
    Moreno Gonzalez, E.
    TRANSPLANTATION, 2012, 94 (10) : 46 - 46
  • [9] Sirolimus-induced pulmonary toxicity in heart and lung transplant recipients.
    Ayache, Mirna B.
    Budev, Marie
    Haire, Christiana
    Yamani, Mohamad H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 420 - 420
  • [10] Exposure to CsA, and not to everolimus, is associated with impaired renal function in de novo heart transplant recipients.
    Varnous, Shaida
    Livi, Ugolino
    Poncelet, Alain
    Delgado, Juan
    Vermes, Emmanuelle
    Li, Yulan
    Arizon, Jose
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 346 - 346
12345